If youre interested in beginning GLP-1 therapy for weight loss, reach out to Affinity Urgent Care
Highlights of Prescribing Information for Zepbound
Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis
The FDA announced that Ozempic and Wegovy supply problems had ended and set final deadlines for pharmacies to stop making compounded semaglutide: Individual pharmacy locations: Required to stop by April 22, 2025 Commercial compounding operations: Discontinue production by May 22, 2025 So, compounded semaglutide was not available after May 22, 2025, except in exceptional medical circumstances where standard formulations are ineffective
32 Fortunately, successful introduction of GLP-1 drugs into clinical practice has facilitated more detailed study of GLP-1 effects on bone health in the human setting ( Figure 3 )
What Drives the Tolerability Difference